MAM
EPZM

MPM Asset Management’s Epizyme, Inc EPZM Stock Holding History

MPM Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,729,674
Closed -$20.9M – 9
2016
Q4 		$20.9M Hold
1,729,674
– – 9.88% 2
2016
Q3 		$17M Hold
1,729,674
– – 5.58% 3
2016
Q2 		$17.7M Hold
1,729,674
– – 5.75% 3
2016
Q1 		$21M Hold
1,729,674
– – 6.5% 4
2015
Q4 		$27.7M Hold
1,729,674
– – 4.94% 3
2015
Q3 		$22.2M Sell
1,729,674
-51,412
-3% -$1.04M 3.42% 4
2015
Q2 		$42.7M Sell
1,781,086
-382,733
-18% -$7.37M 7.15% 3
2015
Q1 		$40.6M Sell
2,163,819
-250,000
-10% -$5.16M 8.67% 3
2014
Q4 		$45.5M Hold
2,413,819
– – 10.12% 2
2014
Q3 		$65.4M Hold
2,413,819
– – 21.41% 2
2014
Q2 		$75.1M Hold
2,413,819
– – 25.27% 2
2014
Q1 		$55M Sell
2,413,819
-466,666
-16% -$14.1M 23.26% 1
2013
Q4 		$59.9M Hold
2,880,485
– – 19.35% 3
2013
Q3 		$115M Hold
2,880,485
– – 32.49% 1
2013
Q2 		$81M Buy
+2,880,485
New +$74M 35.87% 1

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MPM Asset Management's EPZM Position: Q1 2017 in Review

MPM Asset Management sold out of Epizyme, Inc (EPZM) in Q1 2017, closing a stake of 1,729,674 shares — an estimated $20.9M sold.

MPM Asset Management first reported a position in EPZM in Q2 2013 and held it in 15 quarters. The position peaked at $115M in Q3 2013. 95 funds tracked by Wall St. Rank hold EPZM as of Q1 2017.

  • MPM Asset Management reported no remaining Epizyme, Inc position as of Q1 2017 after selling out during the quarter.
  • MPM Asset Management sold 1,729,674 Epizyme, Inc shares in Q1 2017, an estimated $20.9M.
  • MPM Asset Management first reported a position in Epizyme, Inc in Q2 2013 and held it in 15 quarters.
  • MPM Asset Management's Epizyme, Inc position peaked at $115M in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2017.

Based on MPM Asset Management's 13F filing for Q1 2017, filed 15 May 2017.